首页> 外国专利> Reprogramming of human endothelium into hematopoietic multilineage progenitor cells with deterministic factors

Reprogramming of human endothelium into hematopoietic multilineage progenitor cells with deterministic factors

机译:将人内皮细胞重编程为具有确定性因子的造血多谱系祖细胞

摘要

The invention is directed to generation of hematopoietic multi-lineage progenitors (HMLPs) from endothelial cells (ECs) by effecting forced expression of certain transcription factors in the ECs and culturing the ECs in serum free media in the presence of endothelial feeder cells. The HMLPs generated in accordance with this invention can produce erythroid, lymphoid, myeloid, and megakaryocyte cells. These generated HMLPs can be used in therapeutic treatment of disorders including hematopoietic conditions.
机译:本发明涉及通过在EC中强制表达某些转录因子并在内皮饲养细胞存在下在无血清培养基中培养EC来从内皮细胞(EC)产生造血多谱系祖细胞(HMLP)。根据本发明产生的HMLP可以产生类红细胞,淋巴样,髓样和巨核细胞。这些产生的HMLP可以用于包括造血病症的疾病的治疗性治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号